Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Piper Sandler reiterated its Overweight rating on Cogent Biosciences, Inc. Common Stock (NASDAQ:COGT) on August 17, 2026.
Read moreJP Morgan reiterated its Overweight rating on Riot Platforms, Inc. (NASDAQ:RIOT) on August 17, 2026.
Read moreJP Morgan reiterated its Neutral rating on Prudential Financial, Inc. 4.125% Junior Subordinated Notes due 2060 (NYSE:PFH) on August 17, 2026.
Read moreRBC Capital reiterated its Outperform rating on Archrock, Inc. (NYSE:AROC) on August 17, 2026.
Read moreEvercore ISI Group reiterated its Outperform rating on Archrock, Inc. (NYSE:AROC) on August 17, 2026.
Read moreBarclays reiterated its Overweight rating on Viper Energy, Inc. (NASDAQ:VNOM) on August 17, 2026.
Read moreStephens & Co. reiterated its Overweight rating on Watsco, Inc.
Read moreStephens & Co. reiterated its Overweight rating on Watsco, Inc.
Read moreBarclays reiterated its Overweight rating on Occidental Petroleum Corporation (NYSE:OXY) on August 17, 2026.
Read moreArgus Research reiterated its Buy rating on Yum! Brands, Inc.
Read moreJP Morgan reiterated its Neutral rating on Prudential Financial, Inc. (NYSE:PRU) on August 17, 2026.
Read moreBarclays reiterated its Overweight rating on Diamondback Energy, Inc. (NASDAQ:FANG) on August 17, 2026.
Read moreBarclays reiterated its Overweight rating on CBRE Group, Inc. (NYSE:CBRE) on August 17, 2026.
Read moreSeaport Global analysts downgraded JetBlue Airways Corporation (NASDAQ:JBLU) from Buy to Neutral on August 17, 2026.
Read moreFreedom Broker analysts upgraded PrimeEnergy Resources Corporation (NASDAQ:PNRG) from Sell to Hold on August 17, 2026.
Read moreUBS reiterated its Neutral rating on James River Group Holdings, Ltd. (NASDAQ:JRVR) on August 17, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on Bioventus Inc. (NASDAQ:BVS) on August 17, 2026.
Read moreCanaccord Genuity reiterated its Buy rating on Bioventus Inc. (NASDAQ:BVS) on August 17, 2026.
Read moreGuggenheim reiterated its Buy rating on ADC Therapeutics S.A. (NYSE:ADCT) on August 17, 2026.
Read moreBarclays reiterated its Underweight rating on Beyond Meat, Inc. (NASDAQ:BYND) on August 17, 2026.
Read more
